Sam Altman-backed AI biotech announces $1 billion for its lofty goal: adding 10 years to human lifespan

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin studies this year. Read More

https://fortune.com/img-assets/wp-content/uploads/2025/01/GettyImages-2194347600-e1737735267491.jpg?resize=1200,600

2025-01-24 16:22:19